53
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Epidemiology of viral hepatitis and HIV co-infection.

      1
      Journal of hepatology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Worldwide, hepatitis B virus (HBV) accounts for an estimated 370 million chronic infections, hepatitis C virus (HCV) for an estimated 130 million, and HIV for an estimated 40 million. In HIV-infected persons, an estimated 2-4 million have chronic HBV co-infection and 4-5 million have HCV co-infection. HBV, HCV and HIV share common routes of transmission, but they differ in their prevalence by geographic region and the efficiency by which certain types of exposures transmit them. Among HIV-positive persons studied from Western Europe and the USA, chronic HBV infection has been found in 6-14% overall, including 4-6% of heterosexuals, 9-17% of men who have sex with men (MSM), and 7-10% of injection drug users. HCV infection has been found in 25-30% of HIV-positive persons overall; 72-95% of injection drug users, 1-12% of MSM and 9-27% of heterosexuals. The characteristics of HIV infected persons differ according to the co-infecting hepatitis virus, their epidemiologic patterns may change over time, and surveillance systems are needed to monitor their infection patterns in order to ensure that prevention measures are targeted appropriately.

          Related collections

          Author and article information

          Journal
          J Hepatol
          Journal of hepatology
          Elsevier BV
          0168-8278
          0168-8278
          2006
          : 44
          : 1 Suppl
          Affiliations
          [1 ] Division of Viral Hepatitis, Centers for Disease Control and Prevention, Mailstop D-66, Atlanta, GA 30333, USA. mja2@cdc.gov
          Article
          S0168-8278(05)00726-9
          10.1016/j.jhep.2005.11.004
          16352363
          adcd9dee-399a-455e-a0a0-932d68dc81ee
          History

          Comments

          Comment on this article